These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20839385)

  • 1. Meta-analysis: ribavirin plus interferon vs. interferon monotherapy for chronic hepatitic C - an updated Cochrane review.
    Brok J; Gluud LL; Gluud C
    Aliment Pharmacol Ther; 2010 Oct; 32(7):840-50. PubMed ID: 20839385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin plus interferon versus interferon for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005445. PubMed ID: 20091577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin plus interferon versus interferon for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005527. PubMed ID: 19821346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.
    Cummings KJ; Lee SM; West ES; Cid-Ruzafa J; Fein SG; Aoki Y; Sulkowski MS; Goodman SN
    JAMA; 2001 Jan; 285(2):193-9. PubMed ID: 11176813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
    Simin M; Brok J; Stimac D; Gluud C; Gluud LL
    Aliment Pharmacol Ther; 2007 May; 25(10):1153-62. PubMed ID: 17451561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin with or without alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (2):CD002234. PubMed ID: 12076442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud L; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005527. PubMed ID: 16235408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
    Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.
    Gluud LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2007 Jul; 2002(2):CD002234. PubMed ID: 17636700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Am J Gastroenterol; 2006 Apr; 101(4):842-7. PubMed ID: 16494584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review.
    Shepherd J; Waugh N; Hewitson P
    Health Technol Assess; 2000; 4(33):1-67. PubMed ID: 11134916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
    Scott LJ; Perry CM
    Drugs; 2002; 62(3):507-56. PubMed ID: 11827565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.
    Zaman A; Fennerty MB; Keeffe EB
    Aliment Pharmacol Ther; 2003 Oct; 18(7):661-70. PubMed ID: 14510739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.
    Iorio A; Marchesini E; Awad T; Gluud LL
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004888. PubMed ID: 20091566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4.
    Khuroo MS; Khuroo MS; Dahab ST
    Aliment Pharmacol Ther; 2004 Nov; 20(9):931-8. PubMed ID: 15521839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.